BIOLOGY TO BARCODES
LIVE

Serial Number

90364536

Owner

BioSpyder Technologies Inc

Attorney

Leigh Augustine

First Use Date

Mar 30, 2021

Filing Date

Dec 7, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BIOLOGY TO BARCODES Trademark

Serial Number: 90364536 • Registration: 7644688

BIOLOGY TO BARCODES is a trademark filed by BioSpyder Technologies Inc on December 7, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BioSpyder Technologies Inc (11 trademarks)

5922 Farnsworth Ct 102
Carlsbad, CA 92008

Entity Type: 03

Trademark Details

Filing Date

December 7, 2020

Registration Date

January 7, 2025

First Use Anywhere

March 30, 2021

First Use in Commerce

March 30, 2021

Published for Opposition

June 8, 2021

Goods & Services

Chemical reagents for medical or veterinary purposes; Clinical medical reagents; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for veterinary purposes; Diagnostic reagents for medicinal use; Enzyme preparations for medical purposes; Enzyme preparations for veterinary purposes; Enzymes for medical purposes; Enzymes for veterinary purposes; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; Medical diagnostic test strips for use in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, water analysis, and liquid biopsy; Nucleic acid sequences and chemical reagents for medical and veterinary purposes

DNA screening for medical purposes; Genetic testing for medical purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services for the diagnosis of cancer; Medical diagnosis and treatment of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnosis of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical diagnostic testing, monitoring and reporting services; Medical dosimetry services for treating radiation exposure; Medical screening; Medical screening services in the field of cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical services; Medical testing for diagnostic or treatment purposes; Medical testing of urine, blood, hair follicles and breath; Providing cancer screening services; Providing information in the field of cancer prevention, screening, diagnosis and treatment; Providing information in the field of diabetes; Veterinary specialty services providing advanced medical, diagnostic or surgical services for animals

Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Blood component separation apparatus for medical purposes; Blood containers for medical purposes; Blood filters; Blood testing apparatus, namely, blood collecting tubes; Blood testing apparatus, namely, blood sampling tubes; Filters for blood and blood components for medical purposes; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus for detecting cancer; Medical apparatus for diagnosing or treating respiratory conditions; Medical apparatus for diagnosing or treating respiratory conditions, namely, cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; Medical device for detecting cancer; Medical devices for dosimetry purposes in the field of radiotherapy; Medical devices for use in treating or diagnosing cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical devices for use in treating or diagnosing cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk with integrated recorded operating system software, sold as a unit; Medical devices for use in treating or diagnosing cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk with integrated recorded software for detecting labeled molecules and analyzing genetic data, aligning sequences, controlling laboratory equipment, bioinformatics, expression profiling, and metabolic pathways, sold as a unit; Medical diagnostic apparatus for detecting cancer; Medical diagnostic apparatus for testing DNA and RNA samples; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus for testing the presence of nucleic acids and antigens, and modifications thereof, gene expression, tissue structures, radiation exposure; Medical diagnostic apparatus for testing biological samples,  DNA, RNA, proteins, viruses, single cells, tissue, organs, biochemical preparations, and waste water incorporating recorded operating system software; Medical diagnostic instruments for the analysis of body fluids; Medical instruments for analysing and identifying bacteria; Medical instruments for analyzing and identifying bacteria; Medical instruments for use in treating cancer, inherited diseases, infectious disease, viral disease, Covid-19, influenza, respiratory syncytial virus, coronary artery disease risk, and schizophrenia risk; Medical instruments, namely, biosensors for detecting infectious diseases; Medical specimen collection devices in the nature of bottles, tubes, swabs, syringes, and wipes for the collection of nasal mucus, respiratory droplets, saliva, blood, urine, and feces; Sample preparation device for medical diagnostic uses

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 18, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 18, 2024 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2024 TEME
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 10, 2024 CHAN
ASSIGNED TO LIE
Dec 10, 2024 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Aug 1, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Feb 15, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 14, 2024 AITU
USE AMENDMENT FILED
Jan 24, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 24, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 5, 2023 EXRA
SOU EXTENSION 4 GRANTED
Aug 3, 2023 EX4G
SOU EXTENSION 4 FILED
Aug 3, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 3, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 10, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 10, 2023 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2023 EXRA
SOU EXTENSION 3 GRANTED
Jan 31, 2023 EX3G
SOU EXTENSION 3 FILED
Jan 31, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 31, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 2, 2022 EXRA
SOU EXTENSION 2 GRANTED
Jul 29, 2022 EX2G
SOU EXTENSION 2 FILED
Jul 29, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 29, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 5, 2022 EXRA
SOU EXTENSION 1 GRANTED
Feb 3, 2022 EX1G
SOU EXTENSION 1 FILED
Feb 3, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 3, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 13, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 13, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 13, 2021 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 3, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 8, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 8, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 19, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2021 CNSA
ASSIGNED TO EXAMINER
Apr 26, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2021 NWOS
NEW APPLICATION ENTERED
Dec 10, 2020 NWAP